Mallinckrodt

Pharma

Jury awards $885M in Takeda pay-for-delay antitrust case

Takeda plans to appeal after a jury found it liable in a landmark pay-for-delay antitrust case and ordered the Japanese drugmaker to pay $885 million.

Kevin Dunleavy May 19, 2026 8:39am

Keenova launches ‘Don't Be a Viking’ Dupuytren's campaign

May 5, 2026 2:11am

Mergers MA spinoff arrows merging arrows

Mallinckrodt, Endo become Keenova following generics spinoff

Nov 11, 2025 9:54am

A shot from Prime Time Endos branded Peyronies commercial

Endo builds on ‘Bent Carrot’ campaign for fresh Xiaflex push

Aug 12, 2025 12:59pm

merger MA combined company mergers acquisitions business development

Troubled Mallinckrodt, Endo telegraph $6.7B merger plans

Mar 13, 2025 10:18am

BMJ report digs into Mallinckrodt's opioid selling tactics

Jun 10, 2024 6:30pm